دورية أكاديمية
Recurrence following transanal total mesorectal excision for rectal cancer: a monocentric retrospective series of technically difficult cases.
| العنوان: | Recurrence following transanal total mesorectal excision for rectal cancer: a monocentric retrospective series of technically difficult cases. |
|---|---|
| المؤلفون: | Frigault J; Department of Surgery, CHU de Québec - Université Laval, Québec City, QC, Canada., Morin G; Department of Surgery, CHU de Québec - Université Laval, Québec City, QC, Canada., Drolet S; Department of Surgery, CHU de Québec - Université Laval, Québec City, QC, Canada., Bouchard P; Department of Surgery, CHU de Québec - Université Laval, Québec City, QC, Canada., Bouchard A; Department of Surgery, CHU de Québec - Université Laval, Québec City, QC, Canada., Ngo TP; Department of Surgery, CHU de Québec - Université Laval, Québec City, QC, Canada., Letarte F; Department of Surgery, CHU de Québec - Université Laval, Québec City, QC, Canada. |
| المصدر: | Annals of coloproctology [Ann Coloproctol] 2023 Aug; Vol. 39 (4), pp. 332-341. Date of Electronic Publication: 2022 Nov 14. |
| نوع المنشور: | Journal Article |
| اللغة: | English |
| بيانات الدورية: | Publisher: Korean Society of Coloproctology Country of Publication: Korea (South) NLM ID: 101605121 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2287-9714 (Print) Linking ISSN: 22879714 NLM ISO Abbreviation: Ann Coloproctol Subsets: PubMed not MEDLINE |
| أسماء مطبوعة: | Original Publication: Seoul : Korean Society of Coloproctology, [2013]- |
| مستخلص: | Purpose: Transanal total mesorectal excision (TaTME) has been proposed to overcome surgical difficulties encountered during rectal resection, especially for patients having high body mass index or low rectal cancer. The aim of this study was to evaluate oncologic outcomes following TaTME. Methods: This retrospective study included all consecutive patients with rectal cancer who had a TaTME from 2013 to 2019. The main outcome was the incidence of locoregional recurrence by the end of the follow-up period. Results: Among a total of 81 patients, 96.3% were male, and their mean age was 63±9 years. The mean body mass index was 30.3±5.7 kg/m2, and the median distance from tumor to anal verge was 5.0 cm (interquartile range [IQR], 4.0-6.0 cm). Most patients had a low anterior resection performed (n=80, 98.8%) with a diverting ileostomy (n=64, 79.0%). Distal and circumferential resection margins were positive in 2.5% and 6.2% of patients, respectively. Total mesorectal excision was complete or near complete in 95.1% of patients. A successful resection was achieved in 72 patients (88.9%). After a median follow-up of 27.5 months (IQR, 16.7-48.1 months), 4 patients (4.9%) experienced locoregional recurrence. Anastomotic leaks were observed in 21 patients (25.9%). At the end of the follow-up, 69 patients (85.2%) were stoma-free. Conclusion: TaTME was associated with acceptable oncological outcomes, including low locoregional recurrence rates in selected patients with low rectal cancer. Although associated with a high incidence of postoperative morbidities, the use of TaTME enabled a high rate of successful sphincter-saving procedures in selected patients who posed a technical challenge. |
| References: | Surg Endosc. 2016 Aug;30(8):3210-5. (PMID: 26537907) Colorectal Dis. 2018 Sep;20 Suppl 6:33-46. (PMID: 30255642) Can J Surg. 2014 Dec;57(6):405-11. (PMID: 25421083) Surg Endosc. 2022 Jan;36(1):167-175. (PMID: 33416990) Br J Surg. 2020 Jan;107(1):121-130. (PMID: 31802481) Br J Surg. 2020 Aug;107(9):1211-1220. (PMID: 32246472) Br J Surg. 2019 Aug;106(9):1120-1121. (PMID: 31304578) Surg Endosc. 2010 May;24(5):1205-10. (PMID: 20186432) Surg Endosc. 2016 Feb;30(2):464-470. (PMID: 25921202) Surg Endosc. 2018 Mar;32(3):1091-1103. (PMID: 29234940) Surg Endosc. 2018 May;32(5):2312-2321. (PMID: 29098433) J Clin Oncol. 2002 Apr 1;20(7):1729-34. (PMID: 11919228) Ann Surg. 2019 Apr;269(4):700-711. (PMID: 29315090) Ann Surg. 2017 Jul;266(1):111-117. (PMID: 27735827) Surg Endosc. 2015 Dec;29(12):3608-17. (PMID: 25743996) Surgery. 2009 Sep;146(3):483-9. (PMID: 19715805) Tech Coloproctol. 2018 Apr;22(4):279-287. (PMID: 29569099) Ann Surg. 2004 Aug;240(2):205-13. (PMID: 15273542) Surg Endosc. 2021 Feb;35(2):826-836. (PMID: 32072292) Lancet Oncol. 2013 Mar;14(3):210-8. (PMID: 23395398) J Am Coll Surg. 2019 Mar;228(3):235-244.e1. (PMID: 30639298) Tech Coloproctol. 2016 Dec;20(12):811-824. (PMID: 27853973) Br J Surg. 1982 Oct;69(10):613-6. (PMID: 6751457) Br J Surg. 1998 Mar;85(3):355-8. (PMID: 9529492) Tech Coloproctol. 2016 Mar;20(3):185-91. (PMID: 26754653) JAMA. 2015 Oct 6;314(13):1346-55. (PMID: 26441179) Tech Coloproctol. 2019 Sep;23(9):903-911. (PMID: 31599385) Surg Endosc. 2020 Sep;34(9):4101-4109. (PMID: 31602515) Tech Coloproctol. 2016 Jun;20(6):343-352. (PMID: 27015679) BMC Cancer. 2016 Jul 04;16:380. (PMID: 27377924) J Am Coll Surg. 2015 Aug;221(2):415-23. (PMID: 26206640) Surgery. 2010 Mar;147(3):339-51. (PMID: 20004450) BMC Cancer. 2017 Apr 11;17(1):253. (PMID: 28399840) Clin Colon Rectal Surg. 2017 Nov;30(5):339-345. (PMID: 29184469) Surg Endosc. 2020 Jan;34(1):192-201. (PMID: 30888498) Ann Surg. 2015 Feb;261(2):221-7. (PMID: 25185463) Colorectal Dis. 2016 Dec;18(12):1154-1161. (PMID: 27218423) BMJ Open Gastroenterol. 2019 Jun 21;6(1):e000305. (PMID: 31297232) Surg Endosc. 2020 Sep;34(9):3908-3919. (PMID: 31617090) Clin Colon Rectal Surg. 2020 May;33(3):134-143. (PMID: 32351336) Surg Endosc. 2020 Apr;34(4):1534-1542. (PMID: 29998391) |
| فهرسة مساهمة: | Keywords: Local neoplasm recurrence; Rectal neoplasms; Transanal endoscopic surgery |
| تواريخ الأحداث: | Date Created: 20221114 Latest Revision: 20230906 |
| رمز التحديث: | 20240628 |
| مُعرف محوري في PubMed: | PMC10475802 |
| DOI: | 10.3393/ac.2022.00178.0025 |
| PMID: | 36375445 |
| قاعدة البيانات: | MEDLINE |
Full Text Finder كن أول من يترك تعليقا!